Laurus Labs Limited, along with its subsidiaries, is involved in the research, production, and distribution of medications and active pharmaceutical ingredients (APIs) both in India and globally. The company specializes in the development and manufacturing of APIs and advanced intermediates for various therapeutic areas such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs Limited also manufactures oral solid formulations for ARVs, anti-diabetic, cardiovascular, PPIs, and central nervous system. The company offers contract development and manufacturing services to pharmaceutical companies and produces specialty ingredients used in nutraceuticals, dietary supplements, and cosmeceutical products. Furthermore, Laurus Labs Limited develops innovative enzymatic solutions for industrial biotechnology and produces animal origin free recombinant proteins and enzymes for biopharmaceuticals. The company also provides business support services to the pharmaceutical industry. Laurus Labs Limited was established in 2005 and is headquartered in Hyderabad, India.
Laurus Labs Limited
- 563.60 5.80(1.04%) 564.30 6.50(1.17%)
Live Laurus Labs Limited Share Price Chart
Laurus Labs Limited Share Performance
| Today's Low | Today's High | |
|---|---|---|
| 551.85 551.90 | 566.55 566.10 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 360.85 (25-Jan-2024) 358.70 (25-Jan-2024) | 619.40 (07-Jan-2025) 619.50 (07-Jan-2025) |
- Open
- 557.80 559.90
- Previous Close
- 557.80 557.80
- Volume
- 9.34
- Total Traded value
- 52.15 (Lakhs)
- Upper circuit
- 613.55 465.05
- Lower circuit
- 502.05 380.55
Laurus Labs Limited Share Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 296,509 | 187,770 |
| Bid Price | Quantity |
|---|---|
| 563.60 | 154.00 |
| 563.55 | 305.00 |
| 563.50 | 141.00 |
| 563.45 | 291.00 |
| 563.40 | 375.00 |
| Total: | 296,509 |
| Ask Price | Quantity |
|---|---|
| 563.95 | 276.00 |
| 564.00 | 712.00 |
| 564.05 | 108.00 |
| 564.10 | 170.00 |
| 564.15 | 943.00 |
| Total: | 187,770 |
Laurus Labs Limited Share Fundamentals
| Market Cap: | 303.87 Cr |
| PE Ratio (TTM): | 127.90 |
| PB Ratio: | 7.04 |
| Industry P/E: | 230.60 |
| Debt to Equity: | 0.00 |
| ROE: | 5.51 |
| EPS (TTM): | 4.36 |
| Book Value: | 75.03 |
| Face Value: | 2.00 |
Laurus Labs Limited Stock Financials
| Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
|---|---|---|---|---|---|
| Revenue | 1,158.03 Cr | 1,107.65 Cr | 1,279.34 Cr | 1,500.70 Cr | 1,498.16 Cr |
| Profit | 46.67 Cr | 13.07 Cr | 102.28 Cr | 199.05 Cr | 227.44 Cr |
| Expense | 1,100.72 Cr | 1,097.11 Cr | 1,148.48 Cr | 1,233.34 Cr | 1,185.58 Cr |
| Comprehensive income | 45.44 Cr | 11.85 Cr | 103.52 Cr | 198.91 Cr | 227.28 Cr |
| EPS | 0.87 | 0.00 | 1.88 | 3.70 | 4.21 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Laurus Labs Limited | Dec, 2016 Dec, 2016 | Pharmaceuticals Pharmaceuticals | LAURUSLABS LAURUSLABS |
Laurus Labs Limited Stock Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Laurus Labs Limited Share FAQ's
What is the range of today's stock performance for Laurus Labs Limited?
Today's stock performance witnessed a fluctuation from a minimum of 551.85 on the NSE (National Stock Exchange) to a maximum of 566.55. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 551.90 to a high of 566.10.
What are the 52-week low and high values for Laurus Labs Limited?
The stock's performance over the past 52 weeks reveals a low of 360.85 (occurred on 25-Jan-2024) and a high of 619.40 (achieved on 07-Jan-2025) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 358.70 (on 25-Jan-2024), and the 52-week high is 619.50 (on 07-Jan-2025).
What was the opening and previous closing prices for Laurus Labs Limited?
The stock's performance over the past 52 weeks reveals a low of 360.85 (occurred on 25-Jan-2024) and a high of 619.40 (achieved on 07-Jan-2025) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 358.70 (on 25-Jan-2024), and the 52-week high is 619.50 (on 07-Jan-2025).
What is the total volume and traded value for Laurus Labs Limited for the day?
The total volume is 9, and the total traded value is 52.15 ( Lakhs).
What are the upper and lower circuit limits for Laurus Labs Limited?
The upper circuit limit is 613.55, and the lower circuit limit is 502.05.
What is the market cap and PE ratio for Laurus Labs Limited?
The market cap is 303.87 Cr, and the PE ratio (TTM) is 230.60.
What is the PB ratio, industry P/E, and debt to equity ratio for Laurus Labs Limited?
The PB ratio is 7.51, industry P/E is 230.60 , and the debt to equity ratio is 0.00.
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Laurus Labs Limited?
ROE is 5.51, EPS is 4.36, book value is 75.03
What are the revenue and profit figures for the latest quarter and previous quarters for Laurus Labs Limited?
In Sep 2023, Revenue is 11580300000.00, and Profit is 466700000.00. In Jun 2023, Revenue is 11076500000.00, and Profit is 130700000.00.
When was Laurus Labs Limited listed, and what industry does it belong to?
The company, Laurus Labs Limited, was listed in Dec 2016 and belongs to the Pharmaceuticals industry. Its NSE symbol is LAURUSLABS.
What is the current shareholding pattern of the Laurus Labs Limited?
As of latest available update, promoters hold 27.20%, the public holds 72.80%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 35
- Threads
- 182
